![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Symptom- und Belastungserfassung mit MIDOS oder IPOS – Kennzahl Symptom- und Bedarfserfassung, KeSBa-Projekt
-
Article
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia
We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive chemotherapies assigned at study-entry and analyzed on a...
-
Article
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
DNA methylation changes are a constant feature of acute myeloid leukemia. Hypomethylating drugs such as azacitidine are active in acute myeloid leukemia (AML) as monotherapy. Azacitidine monotherapy is not cur...
-
Article
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT
Non-relapse mortality after Allo-SCT has significantly decreased over the last years. Nevertheless, relapse remains a major cause for post SCT mortality in patients with AML and high-risk myelodysplastic syndr...
-
Article
CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT
After allo-SCT, analysis of CD34+ lineage-specific donor cell chimerism (DCC) is a sensitive method for monitoring minimal residual disease in patients with AML or myelodysplastic syndrome (MDS) with CD34 express...
-
Article
High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases
Germ cell cancer (GCC) is curable in metastatic stages. The International Germ Cell Cancer Collaborative Group (IGCCCG) reports a poor prognosis subgroup with a 5-year survival of 48%. High-dose chemotherapy w...
-
Article
The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML
Recently, mutations in the transcription factor CCAAT/ enhancer binding protein alpha (C/EBPα) have been described in acute myeloid leukemia (AML). We performed a mutational analysis of the C/EBPα gene in the ...
-
Article
Unreifzellige myeloische Leukämie
Die klinischen Befunde von 14 Patienten mit unreifzelliger myeloischer Leukämie werden in knapper Form mitgeteilt. An den leukämischen Zellen (Myeloblasten, Promyelozyten) wurden folgende Untersuchungen durchg...
-
Article
Referate
-
Article
Buchbesprechungen
-
Article
Referate
-
Article
Referate
-
Article
Buchbesprechungen